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To evaluate the effects of dietary fish o0 an cholesterol .
induced atherosclerosis, 36 New Zealand rabbits in four
groups were fed a 0 .3% cholesterol diet for 10 weeks . One
group served as control, whereas groups I . 11 and III
received 1, 2 and 3 ml/day, respectively, of fish oil (Proto .
chat, eicosapentaenoic acid, 180 mg, and docasahexaenoic
acid IDHAI, 120 mg(ml) . The percent of aortic and pulmo-
nary atherosclerostswas measured by planimetry of sudano-
philic lesions. The percent of aortic lesions in the control
group was 59 m 22% . The two higher dose fish oil groups
showed a significant reduction in aortic lesions : group I (40
t 26%, p = NS), group 11 (I8 ± l I %, p < 0
.01) and group
111(36 ± 22%, p < 0 .05) . Area of pulmonary artery lesions
was significantly higher in the control group (49 ± 22%1 as
compared with group 1 (l5 ± 13%, p < 0 .01), group 11 (4
t 3%, p < 0.01) and group III (8 ± 9%, p < 0
.01).
The high cholesterol diet in the control group decreased
Epidemiologic studies (1,21 have shown an inverse correla-
tion between fish consumption and the prevalence of coro-
nary heart disease in some populations . It has been sug-
gested that this correlation may be due to the high consent of
polyunsaturated fatty acids of the omega-3 group, especially
eicosapentaenoic acid (EPA) in fish oil . A cause and effect
relation between eicosapentaenoic acid and attenuation of
vascular disease was f^,cently shown in animal studies 13-5).
Dietary cod live- : oil (30 ml/day) containing 12% eicosapen-
taenoic acid retarded the development of coronary artery
disease in a hyperlipidemic swine model, possibly through
changes in prostaglandin metabolism (3)
.
Fish oil was shown
to reduce serum cholesterol and inhibit progression of ath-
erosclerosis in rhesus monkeys even though high density
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bleeding time from 82 ± 17 to 59 s 22 s (p < 0
.05)
. Groups
II and Ill showed an incresed bleeding time (62 ± 15 to 04
± 17 s and 66 ± 22 to 9S ± 27 s : p < 0 .05, respectively)
.
Fish oil did not signih:only alter total serum cholesterol
and high density lipoprotein (HDL) cholesterol . In group It
triglyceride decreased from 128 ± 22 to 64 x 25 mgldt (p <
0.001) . Plasma thrnmboxane B e levels decreased to the
same extent in all four groups . There was no correlation
between thromboxane Ba levels and percent of aortic or
pulmonary atherosclerosis. However, there was a modest
correlation between percent lesions in the pulmonary artery
and aorta (r =
0 .6).
This study shows that dietary fish oil tan attenuate the
development of aortic and pulmonary atherosclerosis in
cholesterol-fed rabbits. The increased bleeding time ap-
pears to confirm the known anliptatelet effects of fish oil .
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lipoprotein cholesterol IHDL cholesterol) levels were de-
pressed (4)
.
Rats fed fish oil showed a significant lowering of
plasma cholesterol and triglycerides (5).
In a recent clinical study (6) . a decrease in serum triglyc-
eride of 54% and a decrease in diastolic blood pressure
of 7c/ in 60 male volunteers was attributed to ;akiay sup-
plemental fish o
il. i t -nother study (7). the plasma tnglyc-
eride concentration was reduced significantly in patients
with types llb and IV hyperlipidemia (28 and 41%, respec-
tively)
. The change was significantly correlated with basal
triglyceride levels (r = 0
.94) and was dose related (33% fall
on a regimen of 6 g/day and 58% fall on a regimen of 16 gJ
day).
By contrast, a recent animal study (8) showed that fish oil
enhanced the development of atherosclerosis in rabbits . In
diabetic rats, fish oil increased plasma free fatty acids and
triacylglycerols (9) . In a clinical study (10) . although serum
triglycerides decreased, the level of low density lipoprotein
(LDL) apoprtein B fell significantly when hypertriglyceri-
demic patients were treated with fish oil . In the face of these
conflicting results, we designed the present study to further
evaluate the influence of fish oil on cholesterol-induced
0735-09755153
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atherosclerosis in cholesterol-fed rabbits . Different doses Table 1
. Rabbit Weight (kg) Before Treatment and at 5
were given to evaluate the dose-response relation .
Week Intervals"
Methods
Protocol . Thirty-six New Zealand white rabbits (1
.6 to
2 .1 kg) were randomly separated into four groups and fed a
high cholesterol diet for 10 weeks . The cholesterol diet
(Ziegler Bros .
. Inc
.) contained 3% soybean oil and 0.3%
cholesterol by weight. The control group received the diet
only . In addition to the high cholesterol diet, group I was fed
I ml of fish oil every day . (Proto-Chol mix, Banner Gelatin
Products Corp . E. R
. Squibb and Sons). One milliliter of fish
oil contained marine i'pid concentrate, 1,000 mg : eicosapen-
taenoic acid (EPA), 180
mg,
and docosahexaenuic acid
(DHA), 120 ing (35% of the fatty acids was omega-3);
vitamin E. I IU
; cholesterol, 530
.5 mg/10B g, and no vitamin
A or D
. Group 11 was fed fish oil, 2 mllday, and group III
received 3 ml/day . The fish oil was administered daily by
intrabuccal gavage. All animal procedures were carried out
according to the National Institutes of Health guidelines .
Laboratory methods. Weight and food consumption of
the rabbits were measured at the beginning of the experimene
and at 5 week intervals thereafter. All rabbits ate approxi-
mately 155 g of feed each day . Blood samples were obtained
at the beginning of the experiment and at 5 week intervals for
calcium and lipid determinations . Total serum cholesterol
and triglyceride levels were determined by automated enzy-
matic methods (Enzymatic Cholesterol Reagent, Trig-Gpo
Reagent, Behring Diagnosis
; Dacos Coulter Electronics,
Inc .) ; HDL cholesterol concentrations were measured after
precipitation of other lipoprotein classes with dextran and
magnesium ions (Fioorescence Light Scattering Mullistat 111
Plus, instrumentatio r laboratory microcentrifugal analyzer) .
Thromboxane B2 was measured on plasma samples (thawed
from -80'C storage with the use of direct radioimmanoassay
kits from Biotecx Laboratories) .
Determination
of bleeding rime was performed by warm-
ing the rabbit ear for 5 min in a normal saline bath maintained
at a temperature of 37°C . The ear was then removed from the
bath and a standard prick was made into the ear avoiding any
macroscopically obvious vessels . The incised ear was then
immediately replaced into the saline bath, which was gently
agitated with a magnetic stirrer
. The bleeding time was taken
as the time required for blood flow from the incision to
cease . Each result represents the mean of two determina-
tions (11) .
Morphologic studies
. Rabbits were killed by an intraperi-
toneal injection of sodium pentobarbital, 60 mg/k ;. The
chest was opened and the aorta was dissected from its origin
at the aortic valve to 2 em beyond the bifurcation of the
internal iliac arteries
. The pulmonary artery was dissected
from its origin at the pulmonary valve to the hila beyond the
bifurcation
. The vasculature was opened longitudinally,
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Group Pre nice 5 Weeks 10 Weeks
Control 1.6x0 .1 2510 .3 3.3!0 .3
1 1.6 0 .2 2.8 ,0 .5 3.3x0 .6
11 1.6 0 .1 7.9 3.5x0 .4
111 2 .1!0.7 3 .2x0 .3 3
.730 .4
'There were no statistical differences between the three treatment groups
and the control group . 1 . II and 111 = groups fed I, 2 and 3 mllday fish oil .
respectively
.
pinned endothelial side up to a cork board and placed in a
saline bath . The aola and pulmonary artery were fixed in
10% formalin, stained with Sudan IV and photographed . The
stained lesions of the aorta and pulmonary artery surface
were estimated quantitatively by planimetry of the sudano-
philia in the photographs . We did not determine the thick-
ness of the lesions. The planimetric determinations were
performed blindly and average values were calculated from
two determinations .
Statistical analysis. Data were subjected to an analysis of
variance using the method of Dunnetl ; Student's paired r test
was used to compare bleeding time before and after dietary
fish oil supplementation . Changes in thromboxane B2, cho-
lesterol, triglycerides and bleeding time, as well as differ-
ences in aortic and pulmonary lesions, were evaluated by
reg:essioo analysis. A log transformation was used for
cholesterol and thromboxane B2. Values in the text and
tables ate expressed as mean values ± I SD
. Statistical
significance was assumed at a p value <0 .05.
Multivariate analysis (multiple regression) was used to
make aortic planimetry the dependent variable and place
baseline cholesterol, final cholesterol, cholesterol change
over 10 weeks, percent cholesterol change over 10 weeks,
percent triglyceride changes, percent bleeding time changes
and fish oil treatment in the regression equation . Data were
processed by a Microvax computer .
Results
Response to diet and drug. There was a similar weight
gain in all groups of rabbits throughout the 10 week period
(Table 1). The serum lipid values for all four groups are listed
in Table 2, and Figure I shows the similar time course of the
increase in serum cholesterol in all groups . There were no
significant differences between the three treated groups and
the control group (C) (p > 0.05) . The serum cholesterol at
the end of 10 weeks in all four groups averaged 1,036 mg/dl .
The mean (±SD) final scrum triglyceride levels (mg/dl) were
as follows: control group ; 122 (±120) ; group 1, 139 (±96) ;
group It, 64 (±25) ; group III, 273 (±190) . There was a
significant decrease of triglyceride in group Il (versus before
diet, p < 0 .001) and a significant increase in group III (versus
IACC Vol. 12 . No .4
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Table 2. Serum Lipid Levels (mg1dlt in the Four Rabbit Groups
Abbreviaians as in Table I .
before diet, p < 0.05) . The mean final serum HDL choles-
terol levels (mg/dl) were : control group,
53 (t
10)
; group 1, 45
(±32); group 11. 27 (±11) ; group 111, 19 '-7). There was a
significant decrease of HDL cholesterol in groups 11 and III
(versus before diet, p < 0.05) .
Table 3
shows changes in bleeding time in the control
group at 10 weeks of the die : (82 t 17 versus 59 ± 22 s, p <
0 .05) and a significant incre : :se in group 11(62 ± 15 versus 84
± 17) and 111(66 t 22 versus 95 t 27 s, p < 0.05) . The low
dose offish oil had no influence on bleeding time in group 1
(70 ± 23 versus 71 ± 16s, p < 0 .05).
The levels of plasma thrambecarte B, were decreased in
all groups at 10 weeks (Table 4). There was no correlation
between changes of thromboxane B 2 (ng/ml) and percent of
lesions in the aorta or pulmonary artery (r = 0 .128). Multiple
regression analysis showed there were no significant inde-
pendent predictors except fish oil treatment . The two higher
doses of fish oil were truly significant independent predic-
tors. Serum calcium levels averaged 13 .31 mg/dl for all four
groups and did not change throughout the 10 weeks.
Morphologic studies
. Figure 2 shows the percent of total
aortic and pulmonary artery surface area exhibiting sudano-
philia for each of the four groups . The aortic lesions were
distributed more frequently in the ascending aorta and at the
vessel branches than elsewhere in the aorta . In rabbits given
the low dose offish oil (group I), the percent of aortic surface
stained by Sudan IV (40 ± 26%) was not significantly
different from that in the central group (59'0 22%) . In rabbits
Figure 1 . Average serum cholesterol levels (mean ± SE) in each
group during the control period and at 5 week intervals . C = control
group ; 1,11, Ill = groups fed 1, 2 and 3 nil/day fish oil .
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given the middle and high dose offish oil (groups 11 and 111,
respectively) the percent of aorta stained
(I8 ± 11%
and 36
± 22%) was less than in the control group (p < 0.01, p <
0.05, respectively). In all three groups given fish oil . the
percent of pulmonary artery surface area stained (15
t
13%o,
4 ± 3%, 8 '- 9%, respectively) was less than in the control
group (48 ± 22%) (all p < 0.01).
The average serum cholesterol levels for each group are
plotted in Figure 3 against the percent of aorta covered by
lesions . The finding that group III had higher mean choles-
terol and triglyceride levels than the other groups (p < 0.05)
may have couttiered to some degree the beneficial effects of
fish oil, so that the extent of lesions was greater than is group
II .
There was a fair positive correlation between the percent
of lesions in the aorta and in the pulmonary artery (r = 0.61,
p < 0 .01 : Y = 0 .54x - 1 .81) (Fig . 4). There were no
correlations between the percent of lesions in the aorta and
changes in cholesterol, triglycerides and bleeding time (r =
0.14, 0 .30 and 0 . 11, respectively) .
Discussion
These results demonstrate that fish oil supplementation of
an atherogenic diet can suppress the development of athero-
sclerosis in rabbits . This finding is consistent with the
speculation that fish oil intake may protect against the
development of atherosclerosis in animals or humans
(3,4,12).
Some contradictory results in rabbits reported
earlier (8) may have been due to different experimental
conditions such as a higher concentrated cholesterol diet
(1 .5%), a longer duration (5 months), greater stress, and so
on
. To date, there have been no other studies evaluating
Table 3. Average Bleeding
Time in the Four Rabbit Groups
Bleeding
Group
Time (s) Control 1 II 111
Pre diet 82 t 17 70
0
23 62
0 15 66 = 22
5 weeks 62 0 IS' 57 ± 25 86 5
20' 77 0 23
10 weeks 59
V
22'
71 t 16 84 0
0 -
95 0 271
'p
< 0.05 when compared with the pre diet value
. Abbreviations as in
Table I .
Group
Cholesterol Triglycerides HDL Cholesterol
Pre Diet 10 Weeks Pre Diet 10 WeeksPre Diet 10 Weeks
Comrol III 0 58 1,117 t 409 109025 1225120 5009 53210
1
81
T_ 38 729 0 414 117 ^ 64 119
s_
96 36 _ 9 45 m 32
11 103 t 40 851 0 401 128 t 22 64 *_ 25 44 *_ 15 27 0 11
111 59 *_ 17 1 .415 0 424 i35 0 42 273 0 190 34 0 11 19-7
-Them were no slerisical differences between the three treatment groups
and the control group. Abbreviations as in Table 1 .
inhibition of atherosclerosis in the pulmonary artery
. Our
results showed that fish oil can suppress the development of
atherosclerosis in the pulmonary artery as well as the aorta .
However, lesions in the pulmonary artery were less severe
than in the aorta
. There was only a modest correlation
between severity of lesions of the pulmonary artery and
aorta in all rabbits (Fig. 4) .
Dose-response relation to fish oil. One purpose of this
study was to evaluate a dose-response relation to fish oil . We
used three doses of fish oil in these approximately 2 kg
rabbits : I ml/day (eicosapentaenuic acid (EPA), 180 and
docosahexaenoic acid (DHA), 120 mg/day)
; 2 ml/day (eico-
sapentaenoic acid (EPA), 360 and DHA, 240 mg/day) and 3
mllday (EPA, 540 and DHA. 360 mg/day) . The middle dose
of 2 ml/day (EPA, 3,560 and DHA, 2,450 mg/day) showed
the greatest inhibition of atherosclerosis in both the aorta
and the pulmonary artery
. A variety of doses have been used
in other studies: 30 ml/day fish cil was fed to swine (12%
EPA, 240 to 360 mg EPA/kg per day) for 5 months
(3) ; 2 mg/
day to rabbits (18% EPA, 180 mg EPA/kg per day) for 8
months (8) ; and 12% tuna fish oil (20 to 22% EPA) to rats for
Figure 2. Percent of aortic (solid bars) and pulmonary artery
(hatched bars) surface areas covered by p!agee for each group .
Comparison of means in aorta, group I versus C, p = NS
; II versus
C, p < 0.01 ; Ill versus C, p < 0 .05
; compared with control group
pulmonary artery, all p < 0 .01 . Abbreviations as in Figure I
.
C
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Figure 3 . Average serum cholesterol during the high cholesterol diet
versus the percent of aortic surface covered by plaque for each
group. Abbreviations as in Figure 1 .
8 months (4) . In addition to these animal studies, doses in
normal volunteers were (10 to 16 ml(g)/day, 0.2 to 0 .4 ml/kg
per day for 3 to 6 weeks) and in patients with hyperlipidemia
(6 to 16 g/day far I to 3 months) (6,7,10) . It appears that the
dose-response relation differs across species . In any event,
in our studies the dose of 2 ml/day was optimal and well
tolerated by the rabbits .
Effect on cholesterol and triglycerides . According to some
studies, consumption of fish oi! can lead to a reduction in
serum cholesterol and triglycerides. However, the published
data concerning changes in HDL cholesterol are conflicting,
with results ranging from an increase to a decrease
. In our
study, although serum cholesterol increased in all groups of
rabbits on the atherogenic diet, there was no significant
difference among the three fish oil-treated groups and the
control group. Only the middle dose offish oil resulted in a
reduction of triglycerides (-32%) similar to that in recent
studies (6,7,13-17). Fish oil may lower triglyceride levels by
inhibiting the synthesis of very low density lipoprotein
(VLDL) triglyceride or by enhancing its clearance in the
periphery (13,14) . Whatever the mechanism, some studies
(7,15,16) suggest that fish oil may be therapeutically useful
for hypertriglyceridemia .
Although all rabbits had severe hyperlipidemia through-
out the study, the differences in the extent of aortic or
pulmonary artery atherosclerosis were not related to differ-
Figure 4. Relation between percent of plaque of aorta and pulmo-
nary artery (PA) in all 36
rabbits (r = 0.61, p < 0 .01 ; y = 0 .54 x
-1 .81).
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Table 4 . Plasma Thromboxane B, Levels Inglmi) Before
Treatment and at 5 Week Intervals"
w- ±
JACC Val . 12, No. 4
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Group Pre Dies 5
Weeks 10 Weeks
S ~
Control 32 .5 x 26.8 L7 x 2 .3 2 .0 2 3.4
±
1 11 .6 9.0
10 .8 8x 1 5.1 1 .9^_L5
8
III
11
111
36 .0x45.1 8 .3_11 .7
351x81 .5 1 .922 .3
2 .9
6.628.7
g8
t0
11
x p
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ences in plasma lipid levels. Therefore, our data suggest that
the fish oil-induced decrease in extent of atherosclerosis in
rabbits was unrelated to changes in plasma lipids, especially
serum cholesterol levels .
Effect on platelets and rheologic properties of bland. Many
factors are known to influence the progression of atheroscle-
rosis . These include monocyte adherence and migration,
endothelial injury, platelet aggregation and lipid accumula-
tion . However, the dose offish oil needed to affect the lipid
concentrations in the serum is generally greater than that
needed to affect the platelet eicosapentaenoic acid concen-
tration . Many studies (3,6,12) have shown that fish oil
increases bleeding time, a finding that is consistent with
decreased platelet aggregation . We found that bleeding time
was significantly shortened in the control group by the
atherogenic diet. Some studies (18) have demonstrated that
LDL cholesterol and platelets in patients with type Ila
hyperlipoproteinemia contain an increased amount of free
cholesterol relative to the principal solubilizer phospholipid .
Platelets aggregated in response to a ninefold lower concen-
tration of epinephrine and a twofold lower concentration of
adenosine diphosphate (i8) . Thus, :he shortened bleeding
time in the control group may have been due to the hyper-
lipoproteinemia caused by the cholesterol-rich diet .
Fish oil signiftcanrly prolonged the bleeding time in
groups H and 111 (p < 0 .05), even though plasma thrombox-
ane B2 levels were not significantly different among the four
groups . Fish oil can also prolong platelet survival time and
decrease platelet count and plasma levels of platelet factor 4
and beta-thromboglobulin. Eicosapentaenoic acid may re-
duce the platelet-vessel wall interaction (19). Furthermore,
fish oil has been shown (20) to significantly increase eryth-
rocyte deformability and concomitantly reduce whole blood
viscosity. Thus, any change in atherosclerosis that might
occur from a long-term fish diet could well be multifactorial
(6,21). It would seem plausible that the administration of
dietary fish oil might be of some benefit in the treatment of
diseases in which there are changes in the rheologic proper-
ties of blood, as reported in arterial occlusive disease .
Effect on thromboxanes and prostaglandin. Secretion of
thromboxane A2
,
platelet factor 4, beta-ihromboglobulin
and products of the lipoxygenase pathway from activated
platelets may contribute initially to intramural thrombus
formation and the development of atherosclerosis . Fish oil
contains the omega-3 polyunsaturated fatty acid eicosapen-
taenoate (eicosapentaenoic acid). The biosynthesis of throm-
boxanes and prostacyclins from eicosapentaenoic acid
(thromboxane A3 and prostaglandin 1 3 ) rather than from the
precursor arachidonate (thromboxane A 3 and pro'aglandin
1,) may help to reduce the atherosclerotic risk . Thrombox-
ane A3 is considerably less potent than its counterpart
thromboxane A 2 , but prostaglandin 1 3 has biologic activity
similar to that of prostaglandin 1 2, Studies in patients with
atherosclerosis showed that only a high dose of eicosapen-
7HU FT AL .
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taenoic acid alters the pattern of synthesis of thromboxanes
and prostacyclins . A lower dose of eicosapentaenoic acid (I
g/day) was not sufficient to maintain the changes in throm-
boxane A, synthesis . Platelet function was only moderately
inhibited. consistent with the incomplete suppression of
thromboxane A, synthesis (22,23) .
The reasons for the decreased plasma thromboxane B,
levels (Table 41 are nor known, Certainly, one would expect
the thromboxane A, generation from platelets to be in-
creased in atherosclerotic arteries compared with normal
arteries (for example, see reference 24) . However, it was
recently shown in rabbits that thromboxane B, disappears
rapidly from the circulation and that the first metabolite to
appear, I1-dehydro-thromboxane B 2 , is stable for ?90 min
(25). Although this finding suggests that the decreased
thromboxane B, seen here after an atherogenic diet may
result partly from enhanced metabolism of thromboxane B2
in atherosclerotic arteries, this hypothesis remains to be
shown conclusively. It is now known, however, that because
of low plasma thromboxane A2 levels and susceptibility of
thromboxane B2 assays to sampling artifacts related to
platelet activation, I1-dehydro-thromboxane B, is more re-
liable than thromboxane B 2 as a marker for plasma throm-
hoxanr A, levels in rabbits (25) and in humans (26,27) .
Fish oil, intravascular thrombus and atheroselerosls . Some
recent studies suggest that fish oil (eicbsapentaenoie acid)
can inhibit restenosis after coronary angioplasty and bypass
surgery (28,29) and suggest that long-term treatment with
fish oil facilitates endothelium-dependent responsiveness in
porcine coronary arteries before it affects platelet function
(30) . Overall, it me be that fish oil exhibits many effects-
reduction in platelet activity and lipoproteins, production of
thromboxane A
3, prostaglandin 1, and leukotrienes of the
5-series and enhanced endothelium-dependent responsive-
ness-all of which could favorably influence the formation of
intravascular thrombus and the progression of atherosclero-
sis .
Conclusions . These results suggest that dietary fish oil
has potential benefit for retarding cholesterol-induced ath-
erosclerosisinrabbitaortaandpulmonaryartery . ltsantiplate-
let effects (prolonged bleeding time) probably contribute
directly to this beneficial influence.
Fish oil (proto-Cbol) was kindly supplied by Banner Gelatin Products Corp .,
E . R. Squibb and Sons. We thank Caryl Halrop for help in the preparation of
this manuuripl .
References
I . Kagawa Y, Nishizawa
M, Suzuki M, et al. Eicosapolyenaic acids serum
lipids of tapanese islanders with low
incidence of cardiovascular disease.
3 Nov Sci Vitaminol 198A2x:441-53 .
2. Kramhout D . Bosschieler EB . DeLeeennc-Coulander
C . The inverse
107$
	
ZHG ET AL .
FISH OIL INHIBITS OTHEROSCLERGSI3
relation berwcon fish nil consumption nod 29 yenrmonality farm coronary
Load disoaa . N Lost J Med 1915:312 :1205-9,
3. Wooer DO, OdreneIS,LrviroPH,eld Inhibitiorof .theroedcrastsby
cd-liver oil in n hypedlpldemic swine model . N Engl J MW 19%:315 :
B41- .
4 . Davis OR, Vmsclinovitch D, Wisnler RW
. Fish oil inhibits we devel5P
,
cent of alherosderasis in rhesus monkeys laba0Cirvlation 19W
74(suppl11)JI-33,
5. Mclnlosh GH, McLrnnan FL, Lowson CA, BWman FH, Charmdi JS .
The influence, of dietary pas on pksmo lipids, blood penanrol and
eoagulS061 indixs in Nc roe. A :herosduosis l9&<
:55:e25-34.
6. Rogro S, James KS . Bunand BK . Elbe tingon MD, O'Brien JR. Jones
JG. Efleds of fish oil supplemeo an serom Kinds, blood
o ,6c„logical v
panue
bleedng
ti-,
ha-sonic and adabhsa double blind
randomized controlled treat in healthy volunteers . Alhemnderosus
1987,63;1.17-43-
7- Sicuas LA . Hickie 19. Buiurnhvo!!eehnn
F
n„ uhe rBecs of dietary
folly nGds (Mexepa) on plasma lipids and lipoproteins in patients with
hyperlipidenria. Atleroscorosis ISIS :54:75-8.
0. Theiry, 1, Seidel D. Fish oil feeding nitwits in an enhancement of
chokstaal-induced xhcrmdcrosis in rabbis . Atherosderasis 1987;63:
13fi.
9. 111mnn RJ . Trimble RP . SlorerOB . Topping DL, OlivccriR . Time-eonrse
or changes in plasma lipids in diabetic rats fed diet high in fish oil or
sallower oile, Atheroscler sis 1906:59:313-21 .
10
. Sullivan DR, Sanders TAB. Traynor IM, Thompson (II . I'amdoaical
elevation of LDLuwvrmdn a levels in hypenriglycedJaemic patients
and normal subjects ingesting fish all, Atherosclerosis I90L :6l :129-34 .
H
. Blalchman MA, Senyi AF, Hirsh J, Genton E, George JN . Hemostatic
function . survival. and mcmhrane glyc0protein clangs in
70000
versus
old rabbit platelets . 3 Clin Invest 1981 :65:1289-94,
12 . Saw., R, Ve el D, Gillotl T. The long-term
effect
ordietwy supplemat-
talion with fish lipids concentrate nn serum lipids, flooding lime . ploelds
and angina. Alherosderes I9$4;55,3-10,
13
. Harris WS, Con= WE, inkeles SO, Ilingwonh DR . Dietary omego3
folly voids prevent carhnhydmte-induced hypenripryceridernm . Mrlabo-
lism 1984:33:1016-9.
14. Nestei Pd, Cannot WE . Reardon MF, Cormar 9, Wang S, Boston R
.
Suppression by diet rich in fish it of very low density kpoprotcin
producrim, in man, J Clin h,vesl 1984 ;74:82-9.
15. Sanders T.AB . Sulbvan DR, Reeve J, Thompson GR
. Triglyceride-
lowering effed of maitre wlyunawmles in patients with hypenriglycer-
idemia
. Atheroselermis 19RS ;5
:da9-65
.
16. Phillipsnn BE, Rothrock DW, Connor WE
. Bards WS, Illingwonh DR.
Reducliun of plasma lipids, Bpoprooins nod apopraleins by dietary fLsh
oil in posim0a with hypendglyceridetda . N Enrol J Men 19X5',112'. 1210.6.
JACC V
.I
. 12. N0. 4
Oeeaber 1988:1073A
17 . Singer P, Berger 1, Luck K. T0ube C, Naumann E, Godieke W .
Long-term effect of mackerel diet on blood pressure, serum lipids and
thromboaane formation In patients with mild essential hypertension .
.Atheensdaernis I986 ;62d59fi5.
19 . Shauil S7, Burnell JS, Colman RW, Cooper RA . Abnormalities of
cholonleral-phospholipid composition in platelets and low-density lipo-
protein of
h- . .
hyperbetalipoproninemio. J Lab Clin Med 1977$9 :341-
53
.
19 . Hay CRM, Duster AP, Saynor R. Effect of fish oil on platelet lonelier in
pal'onts with ischemic hears disease. Lancet 19d2 ;1a269-70.
20. Canwrighr H, Packley AG
. Galloway OH, Greaves M . Preston PE . The
e0acts of dietary
omega-3 polyuasatasted tally acids on
erylhrocyle
membrane phospholipids, erythrocyte defonnahliry,
and blood viscosity
in healthy volunteers. Alherasclcrasis 1935155:267-81,
21 . Eichner ER . Platelets. carotids, and coronaries-crilique on and
Ihrombolic role of antiplate:el agnts, exercise and -lain diems . Am J
hod 1934;77
;513-21
22. Knapp HR, Reilly JAG, AEessanddni ChBP, FiloGerald GA . In vitro
indexes of platelet and vascular function during Bshroil administration m
patients with atherosclerosis . N Enll I Med 1986;314:937-42 .
23. Mehl"J. Lopez IM, Wargovich T. Eicosepenraenoic acid : its relevance in
atheroselermis and coronary salary disease . Am 1 Cardiel 1917;59,155-9.
24. Zmuda A, DembinskaKiec A, ChytkowsRi A, Gryglcwski Rl- Rxped.
mental
atherosckrasis In rabbits : plamlel nggrsEaBOn. thrembre one A a
general€anL add aoi'apgcgatmy poter oy of psoelooycha . Praslzglardins
197704 ;1035-02 .
25, Wastlund P. Knmlin M. Nordenslrom A, Cranstrom E . Circalafiag and
urinary lhromboaace B2 nnaboliles in the rabbit : Itdehydothmmbor
aneB2anparamewoFihva ion-ateproduction-R,ns.padins19%11:
417-03.
26. Ciabboloni A . Maclouf J, Canellu F . Fitzgerald
GA. Palroeo C, Radiaim .
muroassay of 11-dehydrathromboznae H2 in human plasma and urine
.
Biochim Blophys ARIa 1987;918:293-7 .
27. Wodlund P, Gmnsnam E. Kumlin M . Norderntmm A . Wmnilcation of
I l-dehydto-TXE2 as a suitable paromeser far monitoring
thrmnboanne
production in the human . Prostagladim 1936151 :929-d0.
28 FildortoaCP., Vsr'Fa,nnrl I, Ore CM, S001b M, dnif nor B, loaner WK . Cat
coal fish oil supplement minimize re-srenmis after percamneous Honshu .
ngnal emanary angioplasly? labolrl
. J Am Coll Candid 1987
;9 :64A.
29, Davidson MH, MoKennaR
. Sullivan OP, Lisp- PR, Schossuflogor JA,
Maser JV, The
elect of marine oil in conjunainn with other antiplalelet
agents on bleeding lime and plasma lipids (abstr) . 1 Am Call Candid
19019x85A,
30
. Schimakawa H. Lam JY'1', Brion, EJW. Chesebro DO, Venhoarm PM .
Chronic troatment with cod Byer oil facilitates endothelium-dependent
responsiveness in porcine coronary arteries (abstr). 1 Am Coll Candid
19179:2wA.
